Page last updated: 2024-08-17

cycloserine and Weight Gain

cycloserine has been researched along with Weight Gain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fewell, L; Kass, AE; Lenze, EJ; Levinson, CA; McCallum, K; Riley, EN; Rodebaugh, TL; Stark, L	1
Geiter, LJ; Lyle, MA; O'Brien, RJ	1

Trials

2 trial(s) available for cycloserine and Weight Gain

Article	Year
D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:6 Topics: Adolescent; Adult; Anorexia Nervosa; Body Mass Index; Combined Modality Therapy; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Female; Humans; Implosive Therapy; Male; Middle Aged; Pilot Projects; Weight Gain; Young Adult	2015
Rifabutin (ansamycin LM427) for the treatment of pulmonary Mycobacterium avium complex. The American review of respiratory disease, 1990, Volume: 141, Issue:4 Pt 1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Clofazimine; Cycloserine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Respiratory Function Tests; Rifabutin; Rifamycins; Sex Factors; Sputum; Survival Rate; Tuberculosis, Pulmonary; Weight Gain	1990

Article

Year

D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.

The Journal of clinical psychiatry, 2015, Volume: 76, Issue:6

Topics: Adolescent; Adult; Anorexia Nervosa; Body Mass Index; Combined Modality Therapy; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Female; Humans; Implosive Therapy; Male; Middle Aged; Pilot Projects; Weight Gain; Young Adult

2015

Rifabutin (ansamycin LM427) for the treatment of pulmonary Mycobacterium avium complex.

The American review of respiratory disease, 1990, Volume: 141, Issue:4 Pt 1

Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Clofazimine; Cycloserine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Respiratory Function Tests; Rifabutin; Rifamycins; Sex Factors; Sputum; Survival Rate; Tuberculosis, Pulmonary; Weight Gain

1990